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Abstract
Background: Enterococcus faecalis is one of the leading agents of nosocomial infections. To cause diseases, pathogens or
opportunistic bacteria have to adapt and survive to the defense systems encountered in the host. One of the most
important compounds of the host innate defense response against invading microorganisms is lysozyme. It is found in a
wide variety of body fluids, as well as in cells of the innate immune system. Lysozyme could act either as a muramidase and/
or as a cationic antimicrobial peptide. Like Staphylococcus aureus, E. faecalis is one of the few bacteria that are completely
lysozyme resistant.
Results: This study revealed that oatA (O-acetyl transferase) and dlt (D-Alanylation of lipoteicoic acids) genes contribute only
partly to the lysozyme resistance of E. faecalis and that a specific transcriptional regulator, the extracytoplasmic function
SigV sigma factor plays a key role in this event. Indeed, the sigV single mutant is as sensitive as the oatA/dltA double mutant,
and the sigV/oatA/dltA triple mutant displays the highest level of lysozyme sensitivity suggesting synergistic effects of these
genes. In S. aureus, mutation of both oatA and dlt genes abolishes completely the lysozyme resistance, whereas this is not
the case in E. faecalis. Interestingly SigV does not control neither oatA nor dlt genes. Moreover, the sigV mutants clearly
showed a reduced capacity to colonize host tissues, as they are significantly less recovered than the parental JH2-2 strain
from organs of mice subjected to intravenous or urinary tract infections.
Conclusions: This work led to the discovery of an original model of lysozyme resistance mechanism which is obviously more
complex than those described for other Gram positive pathogens. Moreover, our data provide evidences for a direct link
between lysozyme resistance and virulence of E. faecalis.
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Introduction
Enterococcus faecalis is a natural member of the gastrointestinal
tract of humans and animals. This ubiquitous Gram positive
bacterium is abundant in wastewater, on plants, and disseminated
in various ecological niches where fecal contamination occurs
[1,2]. It is also an important microorganism of dairy products and
some strains are even used as probiotics [3].
While E. faecalis is versatile and well suited to survive in hostile
environments, under most circumstances, it does not cause any
harm to the host. However, on some occasions, the commensal
relationship with the host is disrupted leading E. faecalis to cause
serious diseases [4]. Indeed, E. faecalis has emerged as an important
opportunistic pathogen, and one of the major causes of nosocomial
infections such as urinary tract infection, endocarditis, and surgical
wound [5]. In addition, due to its innate and acquired resistances
to several antibiotics including in some cases vancomycin,
conventional therapies are insufficient to threat E. faecalis serious
infections [6]. Although several genes for virulence factors in E.
faecalis have been characterized, and their effects have been
demonstrated in animal models or cultured cells [7], the
mechanisms by which this peaceful commensal became a life-
threatening pathogen are not well understood [4].
As for other pathogens, in order to survive and colonize a given
host, E. faecalis must successfully overcome specific and non specific
host defense mechanisms. One of the most important and widespread
compounds of this defense system against invading micro-organisms
is lysozyme. This enzyme is found in a wide variety of body fluids,
such as tears, breast milk, respiratory and saliva secretions, as well as
in cells of the innate immune system, including neutrophils,
monocytes, macrophages, and epithelial cells [8–10]. Lysozyme acts
on bacteria by hydrolyzing the b-1,4 glycosidic bonds between N-
acetylmuramic acid (MurNAC) and N-acetylglucosamine (Gluc-
NAC), resulting in the degradation of the peptidoglycan (PG), and
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subsequent cell lysis. It has also a cationic anti-microbial peptide
(CAMP) function that leads to bacterial death likely through the
destabilization of the cytoplasmic membrane [11–13].
In contrast to the majority of bacteria, and like some important
human pathogens such as Staphylococcus aureus or Neisseria gonorrhoeae,
E. faecalis is completely resistant to lysozyme. Three main
mechanisms involved in this resistance have been well described
for different species of bacteria. Two of them counteract
antibacterial activity of lysozyme: i) the modification of different
sites of the PG structure by two kinds of enzymes such as the N-
acetylglucosamine deacetylase (PgdA) of Streptococcus pneumoniae
[14], or the peptidoglycan-specific O-acetyltransferase (OatA) of S.
aureus [15] prevents the binding of lysozyme to its substrate and
contributes to the muramidase resistance; ii) the modification of
the net negative charge of the bacterial cell surface by adding
positively charged residues (D-alanine esterification through dlt
genes) to teichoic and lipoteichoic acids helps bacteria to avoid
being killed by antimicrobial peptides or CAMP activity of
lysozyme [13,16]. The third mechanism to evade the killing action
of lysozyme consists on the production of lysozyme inhibitors such
as the streptococcal inhibitor of complement (SIC) in streptococci
[17], the inhibitor of vertebrate lysozyme (Ivy) in E. coli [18], and
the periplasmic (or membrane) lysozyme inhibitor of c-type
lysozyme (named PliC or MliC, in Salmonella enteritidis and E. coli,
respectively) [19], which have protective function.
The availability of E. faecalis genome sequence [20] provides a
tool for the identification of new virulence factors which could help
understanding pathogenicity mechanisms and regulatory compo-
nents, such as alternative sigma factors, that could be involved in
their infection processes. Bacterial sigma factors are a class of
proteins constituting essential dissociable subunits of RNA
polymerase to direct the initiation of the transcription from
specific promoter sequences [21,22]. In addition to the ‘‘house-
keeping’’ sigma factor (i.e. RpoD or s70 of E. coli), most bacteria
have multiple alternative sigma factors that they use to
coordinately regulate the expression of genes whose products are
involved in diverse functions, such as stress responses, iron uptake,
virulence, morphological development, and chemotaxis [23,24].
Like those of Streptococcus pyogenes, S. pneumoniae, and Lactococcus lactis,
the E. faecalis genome lacks a general stress response regulator
homologous to sB of Bacillus subtilis [25]. However, in a previous
work, we have shown that the extracytoplasmic function (ECF)
sigma factor SigV contributes to survival following heat, acid and
ethanol treatments, and is also likely involved in lysozyme
resistance of E. faecalis [26]. In E. faecalis, this lysozyme resistance
was only in part related to oatA gene [27].
This study is dedicated to the continuum of the story of E.
faecalis lysozyme resistance. Based on in silico analyses and on
previous studies [13,16,26,27], we analyzed in depth the role of
some genes involved (oatA) or suspected to be involved (sigV, dlt and
mprF) in the E. faecalis lysozyme resistance. We constructed their
corresponding mutants and analyzed their behavior comparatively
to the parental strain. Thus, we showed that in addition to the
pleiotrophic effects displayed by SigV, it also contributes
importantly to the lysozyme resistance and virulence of E. faecalis.
Results
Identification of genes involved or suspected to be
involved in lysozyme resistance
Based on preliminary results, we have already suggested that
sigV (EF3180) gene encoding an ECF sigma factor is likely involved
in lysozyme resistance of E. faecalis [26]. A further study revealed
that among the two main genes pgdA-like (EF1843) and oatA
(EF0783) able to confer this lysozyme resistance through the
modification of different sites of the PG structure, only oatA has a
significant role in E. faecalis [27].
In the context of cell envelope net charge that may have a role in
lysozyme resistance, we included the analysis of the dlt operon (D-
alanylation of lipoteichoic acids) for which evidence in lysozyme
resistance mechanism was established in S. aureus [13]. The genetic
organization of the dlt operon of E. faecalis as reported by Fabretti
et al., [28] is composed by 4 genes dltA, B, C, and D (EF2749,
EF2748, EF2747, and EF2746, respectively) where dltA encodes a
putative D-alanine-activating enzyme. However, a careful analysis
of the genome sequence of E. faecalis V583 strain revealed an
additional gene dltX (EF2750), upstream of dltA which likely belongs
to the dlt operon (Fig. 1). This gene encodes a putative short protein
(49 amino acid residues), homologous to that described for S. aureus
and highly conserved among Gram positive bacteria [29].
Figure 1. Structural organization of sigV, oatA, dltA and mprF loci. Large arrows correspond to the indicated genes. Grey areas show the
deleted region by double cross over event and that of sigV locus (harbouring an asterisk) represents the deletion carried out in SAS mutant strain. The
solid triangle positioned on EF0031 shows the insertion site of the integrative pUCB300-mprF recombinant plasmid generating the mprF mutant. The
putative promoters and terminators are indicated with P and T letters, respectively. Primers used to construct the different mutants are indicated by
black arrows, and listed in Table 4.
doi:10.1371/journal.pone.0009658.g001
E faecalis Lysozyme Resistance
PLoS ONE | www.plosone.org 2 March 2010 | Volume 5 | Issue 3 | e9658
The in silico analysis of the V583 genome sequence has also revealed
the presence of EF0031 gene, whose product shares 24% identity and
45% homology with MprF (multiple peptide resistance factor) of S.
aureus. This protein contributes to the modification of the membrane
net charge by incorporation of L-lysine to phosphatidylglycerol. This
reduces attractive electrostatic interaction and thereby, the binding of
antimicrobial peptides by bacteria [30]. In addition, Blast searches
using different databanks did not lead to identification of any obvious E.
faecalis homologue to lysozyme inhibitors such as Ivy, Sic, MliC or PliC.
Thus, for this work, we focused on the analysis individually or in
combination of sigV, oatA, dltA, and mprF genes whose structural
organizations are represented in Fig. 1.
Sensitivity to lysozyme
Prior to lysozyme treatment, the parental E. faecalis JH2-2 strain
and its isogenic derivative mutants were tested for their growth
behavior on broth or solid media. Monitoring growth kinetics on
GM17 broth revealed no significant difference for all mutants
relatively to the parental JH2-2 strain (data not shown). Plating the
strains on LB solid medium revealed also a similar result after
48 hours incubation at 37uC in absence of lysozyme (Fig. 2A).
The parental JH2-2 strain and its derivative mutants were tested
for lysozyme sensitivity on LB plates containing large-scale range
of lysozyme concentrations (0 to 20 mg/ml). The wild type JH2-2
strain was not affected in its growth at 20 mg/ml of lysozyme and
even at higher concentrations (data not shown). Surprisingly, also
the mprF insertional mutant was as resistant as the JH2-2 parental
strain (Fig. 2A). This result showed that mprF (suspected to avoid
CAMP activity) is not involved in lysozyme resistance mechanism
of E. faecalis, and was no longer investigated in this work. In
contrast, the other mutants tested do not grow at 20 mg/ml of
lysozyme. Thus, for the histogram representation of the results
(Fig. 2B), this concentration was chosen as the highest limit.
Both oatA and dltA single mutants were similarly more sensitive to
lysozyme than JH2-2 parental strain, but inhibition of growth still
needs at high concentration of lysozyme (about 10 mg/ml) (Fig. 2B).
Figure 2. Susceptibility to lysozyme. The lysozyme sensitivity of E. faecalis JH2-2 and its derivative mutants was tested on LB agar medium.
Overnight cultures were adjusted to OD600 = 1 in physiological water, and diluted up to 10
23. Equal volume of each of the 1021, 1022, and 1023
dilutions are plated on LB solid medium containing large scale range of lysozyme concentrations. (A) Photographs of LB plates after 48 hours
incubation under the indicated lysozyme concentrations. (B) The overall results of the lysozyme sensitivity experiments are summarized in this
histogram.
doi:10.1371/journal.pone.0009658.g002
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This confirms previous results showing that oatA is not the main
effector of E. faecalis lysozyme resistance [27], and that dltA is also
involved in this mechanism. The oatA/dltA double mutant was more
lysozyme sensitive (about 5 mg/ml) than each of the single mutants
(Fig. 2B). This additive effect of both genes is in agreement with the
dual activities (muramidase and CAMP) of lysozyme.
The sigV single mutant showed a sensitivity level (5 mg/ml)
similar to that of oatA/dltA double mutant (Fig. 2A and 2B).
Comparatively to sigV mutant, sigV/oatA and mainly sigV/dltA
double mutants showed increased sensitivity to lysozyme, and
sigV/oatA/dltA triple mutant is the most sensitive (starting from
0.5 mg/ml) among all the strains tested (Fig. 2A and 2B). The
synergistic effect of sigV deficiency in the oatA/dltA double mutant
highlights the key role of the ECF SigV sigma factor in the
lysozyme resistance mechanism of E. faecalis.
In order to confirm the specificity of SigV in its involvement in
lysozyme resistance, we undertook a complementation assay using
JH2-2 parental strain and its derivatives sigV, SAS pMSP3535-sigV
(expressing SigV), SASpMSP3535 (control). Growth on LB solid
medium without (Fig. 3, panel A) or with 20 mg/ml of lysozyme (Fig. 3,
panel B) showed that SigV was able to restore the lysozyme resistance
phenotype even at a concentration of 20 mg/ml (Fig. 3, panel B).
Are oatA and dltA genes under the control of SigV?
Regarding the results reported above, we wondered if there is a
link at the transcriptional level between sigV, dltA, and oatA genes.
Since EF1843 gene (pgdA-like) shares the same promoter sequence
than sigV [26], we included it as a positive control for RT-qPCR
analyses. The results of Table 1 clearly showed that sigV and pgdA-
like are overexpressed when cells were exposed to 3 mg/ml
lysozyme treatment for 30 minutes. Indeed, sigV and pgdA-like
were similarly induced in JH2-2 strain since they are 320 fold and
247 fold overexpressed with significant p values of 0.001 and
0.027, respectively whereas dltA and oatA genes can be considered
as expressed only at a basal level. Under the same conditions,
expression of pgdA-like, dltA, and oatA genes was not significantly
influenced by exposition to lysozyme in the sigV mutant (Table 1).
In the JH2-2 strain, sigV and rsiV genes constituting a bicistronic
operon are expressed in the same way [26] and the rsiV mutant
was as resistant as the parental JH2-2 strain (data not shown).
Regarding that most ECF sigma factors are auto regulated, we
wondered if the overproduction of SigV will lead to consistent
overexpression of sigV and what will be the incidence on the
expression of pgdA-like, dltA, and oatA genes. For this purpose, SigV
was overproduced using SAS pMSP3535-sigV and SAS
pMSP3535 (control) strains under appropriate condition of nisin
(0.5 mg/ml) induction and we analyzed the transcription of these
genes using RT-qPCR. The results reported in Table 2 revealed
that only sigV and pgdA-like genes are drastically overexpressed
(3983 fold and 1992 fold induced, respectively), whereas no
enhanced expression of oatA and dltA genes was observed
demonstrating that both genes are not under the control of SigV.
Is sigV involved in the resistance to CAMP activity?
Both lysozyme and nisin possess a cationic domain involved in
membrane destabilization. To avoid CAMP activity, bacteria have
evolved mechanisms through the reduction of the cell envelope net
charge mainly mediated by dlt genes as it has been described for S.
aureus, E. faecalis and many other bacteria [15,16,28]. In order to
determine whether SigV contributes to the resistance towards
CAMP activities, we monitored growth in the absence or presence
of nisin (the representative model of CAMPs) of sigV and dltA
(control expected to be affected by nisin activity) single mutants
comparatively to E. faecalis JH2-2 parental strain. In the absence of
nisin, all strains had similar growth on GM17 broth (Fig. 4). In the
presence of nisin, the three strains showed a similar prolonged lag
phase (3 hours), and subsequently only the dltA mutant demon-
strated enhanced sensitivity towards nisin (Fig. 4). Interestingly, the
sigV mutant behaved similarly to the parental JH2-2 strain and was
able to grow on GM17 supplemented with 2 mg/ml of nisin after
an adaptation period (Fig. 4). These results strongly suggest that
SigV ECF sigma factor does not contribute to the resistance
towards CAMP activity in the tested conditions.
Triton X-100-induced autolysis assays
Mechanisms affecting the modification of the membrane net
charge or the PG structure play a role in the modulation of
Figure 3. Complementation assay under lysozyme treatment.
The parental strain E. faecalis JH2-2 (1), and its derivative mutants DsigV
(2), SAS pMSP3535 (3), and SAS pMSP3535-sigV (4) were grown on LB
solid medium without lysozyme (A) or supplemented with 20 mg/ml of
lysozyme (B). Five ml of 1022 dilution of overnight cultures adjusted to
OD600 = 1 in physiological water were plated on solid medium,
incubated at 37uC for 48 hours and photographed.
doi:10.1371/journal.pone.0009658.g003
Table 1. RT-qPCR values under lysozyme (3 mg/ml)
treatment.
RT-qPCR(a)
Orfs Gene name JH2-2 DsigV
EF3180 sigV +320
(p = 0.001)
nd
EF1843 pgdA-like +247
(p = 0.027)
21.21
(p = 0.917)
EF2749 dltA +1.83
(p = 0.125)
+1.02
(p = 0.445)
EF0783 oatA +2.4
(p = 0.053)
+1.26
(p = 0.263)
(a)Factor of activation or repression determined by RT-qPCR in JH2-2 wild-type
strain and sigV mutant exposed to 3 mg/ml lysozyme for 30 minutes. Values
.2 with p value ,0.05 are considered as significant. nd, not determined.
doi:10.1371/journal.pone.0009658.t001
Table 2. RT-qPCR values under nisin (0.5 mg/ml) treatment.
Orfs Gene name RT-qPCR(a) Reference 23S
EF3180 sigV +3983 +3191
EF1843 pgdA-like +1992 +1884
EF2749 dltA 21.25 21.5
EF0783 oatA 21.01 +1.1
(a)Factor of activation or repression determined by RT-qPCR when sigV is
overexpressed in the SAS pMSP3535-sigV compared to SAS pMSP3535
(control).
doi:10.1371/journal.pone.0009658.t002
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autolysins activity and thus, may have an impact on bacterial
autolysis [31–34]. In this context, we evaluated the effect of
autolysis induction by triton-X100 on oatA, sigV, dltA single
mutants, sigV/oatA/dltA triple mutant, and JH2-2 wild-type strain.
Over a period of 5 hours, there was a decrease in OD600 nm of
about 50%, and reaching 65% after overnight incubation for all
strains tested towards exposure to 0.05% or 0.1% of Triton X-100
(Fig. 5). This result suggests that oatA, sigV, and dltA genes are not
involved in autolysis process as it was already reported for the dlt
mutant of E. faecalis 12030 strain [28].
SigV is involved in systemic and urinary tract infection
models
In order to assess the effects of oatA, dltA, and/or sigV genes
deletion on the virulence of E. faecalis JH2-2, we compared the fate
of the wild-type and its derivative mutant strains in two different
infection mouse models.
At first, by using a well-established intravenous infection model
[35], we compared tissue burdens in kidneys and livers of groups
of infected mice. As shown in Fig. 6, only sigV and sigV/oatA/dltA
mutants showed statistically significant reductions of tissue burden
both in kidneys and livers. In particular, the sigV mutant exhibited
a reduction of 1.51 logs (p= 0.0058) in kidneys and of 1.37 logs
(p= 0.0155) in livers as compared to the JH2-2 wild-type strain.
Similar results were obtained for the triple mutant (21.77 logs in
the kidney, p= 0.0053; and 21.60 logs in the liver, p= 0.0139),
suggesting that sigV is involved in E. faecalis virulence. However, it
is noteworthy that while non significant, OatA seems to display a
slight reduction of tissue burdens in livers (20.40 logs, p= 0.0546),
following systemic infection in mice as it could be seen in Fig. 6B.
The same strains were also tested in a urinary tract infection
(UTI) model as described elsewhere [36]. The resulting ID50s
showed that only the sigV single and triple mutants required 0.82
and 1.03 log10 more cells (4.6610
3 and 7.46103, respectively) than
did the JH2-2 wild-type strain (6.96102) to infect 50% of the mice,
thereby suggesting that in the UTI model only sigV was implicated
in E. faecalis infection (Fig. 7). Thus, percentages of kidneys of mice
infected for all the bacterial inoculates used were 84% for the JH2-
2 wild-type strain, 58% for the sigV mutant (p= 0.0047), and 53%
for the triple mutant strain (p= 0.0012). Also, the cumulative
difference between the bladders infected with the two strains was
similar to that of the infected kidneys (71% for the JH2-2 versus
40% for the DsigV, p= 0.0066; and 71% for the JH2-2 versus 34%
for the triple mutant, p= 0.0015). The Fig. 7 shows the log10 CFU
recovered from the kidney pairs of mice infected with 104 cells
from JH2-2 or each of mutant strains. As for the systemic infection
model, only the strains DsigV and triple mutant exhibited
statistically significant reductions (21.83 logs for the DsigV,
p= 0.004; and 22.04 logs for the triple mutant, p= 0.0038) in
kidneys tissue burden as compared to the wild-type strain (Fig. 7A).
Similar results were obtained when analyzing bladders. In fact, in
this case also, only sigV single and triple mutants showed
statistically significant reductions (22.42 logs, p= 0.0012; and
22.32 logs, p= 0.0009, respectively) in tissue burdens when
compared to the wild-type strain (Fig. 7B).
Discussion
Environmental adaptation traits and stress resistance mecha-
nisms have been linked to virulence, as bacterial survival in the
host is often reliant on these factors. Despite its ability to adapt to
many different environmental stresses, E. faecalis possesses a
moderate number of regulatory genes [37]. Among these, the
ECF sigma factor SigV was already shown to have a pleiotrophic
effect in the stress response of E. faecalis JH2-2 and was also
suspected to be involved in its lysozyme resistance [26]. This
constitutes a prominent concern since this antimicrobial compo-
nent is considered as the first line of defense of the innate immune
system, and also because E. faecalis is among the few bacteria that
are completely lysozyme resistant.
Lysozyme can affect bacteria by its muramidase and/or CAMP
activities. To overcome the killing action of lysozyme, bacteria
Figure 5. Triton X-100-induced autolysis assays. The autolysis of
E. faecalis JH2-2 (#) and its derivative mutants DsigV (%), DdltA (D),
DoatA (e), and DsigV/oatA/dltA (*) was carried out in Tris-HCl buffer
containing 0.1% of Triton X-100. The autolysis was monitored by
measuring the decrease in OD600 nm of the cell suspensions every
30 min.
doi:10.1371/journal.pone.0009658.g005
Figure 4. Susceptibility to nisin. The sensitivity to nisin of E. faecalis
JH2-2 (N) and its derivative mutants DsigV (&) and DdltA (m) was tested
on GM17 medium (open symbols) or on GM17 supplemented with
2 mg/ml of nisin (solid symbols). The kinetic growth was monitored at
OD600 nm. Mean values of three independent experiments are shown
and standard deviations are indicated.
doi:10.1371/journal.pone.0009658.g004
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have developed different mechanisms among which some are well
dissected. They are mainly based on the modification of the PG
structure (pgdA and oatA for S. pneumoniae [14,38]) associated to the
reduction of the cell surface net charge (oatA and dltA for S. aureus
[13,15], or pgdA, oatA and dlt for L. lactis [39,40]). However, the
wild-type strains of the E. faecalis related lactic acid bacteria S.
pneumoniae R36A [41] and L. lactis MG1363 [39,40] have very low
levels of lysozyme resistance (below 300 mg/ml). In terms of levels
of lysozyme resistance, the most appropriate model for a
comparative study is S. aureus, a human pathogen which also
resists to high concentrations of lysozyme (50 mg/ml) [13,15].
Thus, according to our results, the comparison of the lysozyme
resistance mechanism models between E. faecalis and S. aureus was
summarized in Fig. 8.
In S. aureus, the mechanism of the lysozyme resistance is based
on muramidase (through oatA gene) and predominantly CAMP
activities (through dlt operon). Indeed, the interruptions of both
gene structures (oatA/dltA double mutant) sensitize the bacterium
almost entirely to lysozyme (30 mg/ml) (Fig. 8) [13]. In addition,
these gene structures are under the control of the glycopeptide
resistance associated two-component system (TCS) regulator
GraRS which regulates positively the dlt operon and negatively
the oatA gene [13]. This is not the case for E. faecalis (Fig. 8).
The lysozyme resistance mechanism of E. faecalis is widely
different from those reported above and obviously more complex
as shown in Fig. 8. In E. faecalis, oatA but not pgdA-like was shown
to contribute to lysozyme resistance [27]. Here we demonstrate
that another part of lysozyme resistance (similar level to that
conferred by oatA gene) is due to dlt genes. Since the oatA/dltA
double mutant is twofold more sensitive to lysozyme than the
respective single mutants, the contribution of each system seems to
be additive. However, oatA/dltA double mutant still demonstrates a
relatively high resistance to lysozyme (5 mg/ml), indicating that
oatA and dlt genes can not be considered as the major determinants
of E. faecalis lysozyme resistance. These findings revealed also that
E. faecalis may certainly have additional effectors involved in its
lysozyme resistance.
In this work, in depth investigation showed that sigV single
mutant is as sensitive to lysozyme as oatA/dltA double mutant. In
addition, the sigV deletion associated to that of oatA or dltA lead
systematically to greater lysozyme sensitivity and the lowest level of
resistance (0.5 to 1 mg/ml) was observed for sigV/oatA/dltA triple
mutant. These results demonstrate a synergistic effect of sigV, oatA,
and dltA genes, and confirm the key role of SigV in the lysozyme
resistance of E. faecalis.
The transcriptional results suggest that lysozyme induces
specifically sigV and its potential regulon members as it was shown
for pgdA-like gene. Moreover, the overexpression of sigV either
under lysozyme treatment or nisin induction has no incidence on
the expression of oatA and dltA ruling out both genes from the sigV
regulon. Our analyses showed also that the sigV mutant is not
affected by the CAMP activity of nisin and thereby likely by that of
lysozyme. Moreover, neither dltA nor sigV or oatA do contribute to
the autolysis of E. faecalis JH2-2 under moderate detergent
treatment.
To our knowledge, this is the first study demonstrating that an
ECF sigma factor is the most important effector of lysozyme
resistance in a bacterium. SigV as a transcriptional regulator does
not control neither oatA nor dlt genes but it regulates positively the
pgdA-like gene which was already shown to be not involved in the
Figure 6. SigV is required for the virulence of E. faecalis in a murine systemic model. Enterococcal tissue burdens in kidneys (A) and in livers
(B) from BALB/c mice infected intravenously with 56108 cells of E. faecalis JH2-2 wild-type (N) and its isogenic mutant strains DdltA (&), Doat (m),
DsigV (.), and DdltA-oat-sigV (¤). Kidney pair and livers homogenates were obtained from groups of 10 mice sacrificed and necropsied at day 7
post-infection. Results, expressed as log10 CFUs per gram of tissue, represent values recorded separately for each of the 10 mice. Horizontal bars
represent the geometric means. p value of less than 0.05 was considered to be significant.
doi:10.1371/journal.pone.0009658.g006
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lysozyme resistance of E. faecalis [27]. Taken together our results
argue in favor of a complex and original model of resistance to
lysozyme of E. faecalis (Fig. 8). It is based at least on three effectors,
oatA, dltA and mainly SigV ECF sigma factor through one or more
gene(s) under its control, which remain to be identified.
Since lysozyme is considered as the first line of defense of the
innate immune system, the bacterial resistance towards this
immunogenic compound could be associated to virulence of
pathogens. Regarding elucidated lysozyme resistance mechanisms;
there are evidences in favor of this claiming. Indeed, pgdA of S.
Figure 8. Comparison between the lysozyme resistance effectors of S. aureus and E. faecalis. The lowest concentrations of lysozyme
resistance are indicated in parenthesis (data for S. aureus are from Herbert et al. [13]) and the most relevant are shaded. The relationship to virulence
of the E. faecalis lysozyme resistance effectors is also indicated. Arrows thickness is relatively proportional to the involvement of the considered gene
products in lysozyme resistance or virulence. Blocked arrows correspond to no effect on the considered event. Signs + and – correspond to up and
down-regulation, respectively.
doi:10.1371/journal.pone.0009658.g008
Figure 7. SigV is required for the virulence of E. faecalis in a murine UTI model. Enterococcal burdens of kidneys (A) and bladders (B) of
Balb/c mice infected transurethrally with 104 cells of E. faecalis faecalis JH2-2 wild-type (N) and its isogenic mutant strains DdltA (&), Doat (m), DsigV
(.), and DdltA-oat-sigV (¤). Kidney pair and bladders homogenates were obtained from groups of 15 mice that were sacrificed and necropsied 48 h
after the transurethral challenge. Results, expressed as log10 CFUs per gram of tissue, represent values recorded separately for each mouse. Horizontal
bars represent the geometric means. A value of 0 was assigned to uninfected kidneys or bladders. p value of less than 0.05 was considered to be
significant.
doi:10.1371/journal.pone.0009658.g007
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pneumoniae [41] and dlt genes of S. pyogenes [42], S. suis [43], Listeria
monocytogenes [44] and S. aureus [45,46] are shown to be involved in
the virulence of these pathogens. It was already reported that
MurNAc residues of the PG were O-acetylated only in pathogenic,
lysozyme-resistant staphylococci allowing OatA to be regarded as
a general virulence factor in S. aureus [47]. In association to PgdA,
OatA also affects the fitness of S. pneumoniae [38] and deserves to
retain our attention in the case of E. faecalis. Indeed, we have
shown in a previous study a significant sensitivity in macrophages
survival of the oatA mutant relatively to the wild-type strain [27]. In
the present work, the recovery of this oatA mutant seems only
slightly affected in the intravenous infection model in mice. This
part of virulence could be related to lysozyme resistance as already
hypothesized [27] but independently from SigV. Based on the
assumptions described for intravenous [35] and urinary tract [48]
infections, these observations suggest that OatA may contribute to
the inflammatory response and to the persistence in mouse
peritoneal macrophages but likely not in promoting colonization
and adherence to uroepithelium. In contrast, there is no effect on
virulence attenuation of the E. faecalis dltA mutant comparatively to
the parental JH2-2 strain, at least in the models studied.
Many ECF sigma factors have been described to be involved in
virulence of different bacteria such as Mycobacterium tuberculosis, S.
enterica and Pseudomonas aeruginosa (for review, see [23,24]). In this
work, in addition to lysozyme resistance, the most striking role we
have defined for SigV is its involvement in the virulence of E. faecalis.
Using murine models of intravenous or UTI infections we
demonstrated that in each of the tests applied, E. faecalis cells
lacking a functional sigV gene were significantly impaired in their
ability to establish and maintain infection for which a major
hallmark is systemic dissemination, moving from the site of infection
into the kidneys. In our analyses, the sigV and sigV/oatA/dltA
mutants clearly showed a reduced capacity to colonize host tissues,
as they are unambiguously less recovered from organs of mice
subjected to intravenous or UTI infections than the wild-type JH2-2
strain. This demonstrates that SigV ECF sigma factor is certainly
and more globally involved in virulence of E. faecalis. Interestingly,
our results allowed also establishing through oatA and mainly sigV a
direct link between lysozyme resistance and virulence of E. faecalis.
Unlike GraRS TCS regulator which controls the main effectors
of the lysozyme resistance of S. aureus, SigV has no effect on dlt or
oatA gene expressions (Fig. 8) arguing that hitherto unknown
activities and mechanisms are responsible for this phenomenon in
E. faecalis. On the other hand, the role of SigV could be paralleled
to that of sS, an ECF sigma factor of S. aureus recently described
[49] as both are important components of the stress and
pathogenic responses. In absence of a general stress response
regulator in the genome sequence of E. faecalis, it appears that
SigV can fulfill this role, at least in part, since it is not only
involved in the response to harsh conditions [26] but also in the
lysozyme resistance and virulence.
This work provides actual new insights that may help the
investigation for new targets for antimicrobial drug development.
The future purpose of our laboratory is to explore the mechanisms by
which SigV constitutes an important regulatory component of the
stress and pathogenic responses of E. faecalis in order to strengthen our
knowledge about this potent opportunistic human pathogen.
Materials and Methods
Ethics statement
Murine work was performed under a protocol approved by the
Institutional Animal Use and Care Committee at Universita`
Cattolica del S. Cuore, Rome, Italy.
Bacterial strains, plasmids, and culture conditions
Bacterial strains, plasmids, and oligonucleotide primers used in
the present work are listed in Tables 3 and 4, respectively. E.
faecalis JH2-2 strain and its derivatives were grown at 37uC
without shaking, in M17 medium [50] supplemented with 0.5%
glucose (GM17), or on otherwise specified media depending on
requirements of the experiments. E. coli Top10F’ strain was
cultured with vigorous shaking at 37uC in LB broth. When
required erythromycin (100 mg/ml) or ampicillin (100 mg/ml)
was added.
DNA manipulations
Restriction endonucleases and T4 ligase were obtained from
Promega (Madison, Wi) and used in accordance with the
manufacturer’s instructions. Plasmids and PCR products were
purified using Nucleospin plasmid and nucleospin extract II kits
(Macherey-Nagel, Du¨ren, Germany). Molecular cloning and other
standard techniques were preformed essentially as previously
described [51]. E. coli and E. faecalis strains were transformed by
electroporation using Gene Pulseur Xcell (Bio-Rad Laboratories,
Richmond, Ca, USA) as described by Dower et al., [52] and Holo
and Nes [53], respectively.
Deletion mutagenesis
The construction of the JH2-2 derivative mutants was carried
out with the pMAD plasmid by exploiting its property of
thermo sensitive conditional replication [54]. Briefly, two
fragments of approximately 900 bp corresponding to the
flanking regions (including the 59 and the 39end parts,
respectively) of the target genes were amplified by PCR using
appropriate primers (Table 4). Then, they were purified,
restricted with appropriate endonucleases and ligated into the
pMAD vector in order to generate truncated allele of the gene
of interest where the most part of the coding sequence (CDS)
was deleted (60 to 80% of the CDS corresponding to the
median part of the gene). The ligation mixture was transformed
by electroporation into E. coli Top10F’ cells. After selection and
verification, the generated recombinant plasmids were used to
transform E. faecalis JH2-2 electrocompetent cells and gene
replacement was performed via double cross over events as
described previously [27].
Construction of the mprF insertional mutant
The mprF insertionnal mutant was constructed following
another procedure. Briefly, an internal fragment of mprF gene
was amplified by PCR with specific primers (Table 4), digested by
EcoRI and PstI and ligated in the suicide vector pUCB300 [55]
previously treated with the same enzymes. The ligation product
was electroporated into E. coli Top10F’ cells. The subsequent
recombinant plasmid (pUCB300-mprF) (Table 3) was transformed
in E. faecalis JH2-2. The generated derivative mutant
(mprF::pUCB300) (Table 3) was verified by PCR for the insertion
of the recombinant plasmid pUCB300-mprF within the chromo-
some leading to inactivated mprF gene.
Lysozyme sensitivity
Lysozyme sensitivity assays were performed on LB medium
plates containing different concentrations (0 to 20 mg/ml) of hen
egg white lysozyme (HEWL) (Fluka, Buchs, Switzerland). Over-
night cultures of the parental JH2-2 strain and its derivative
mutants were adjusted to OD600 of 1 in physiological water, and
diluted up to 1023. An equal volume (5 ml) of the 1021, 1022, and
1023 dilutions was then spotted on LB plates with, or without
E faecalis Lysozyme Resistance
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Table 4. Oligonucleotide primers used in this study.
Primer name Forward primer * Reverse primer * Operation
dltA 5-6 CGACAACTGaaTTCAGCTGTAAG (EcoRI) ATTCTCCGTAgtCGACAATCGCTG (SalI) pMAD Cloning
dltA 7-8 GGAAAGTTAGTCGAcAACCTATTG (SalI) ACGATCGATGGAtCCTGAAGAAAT (BamHI) pMAD Cloning
sigV 2V-FT3 TCCGAGGAAtTCCTGCAAGGT (EcoRI) GGATGGCCTgCAGTGCCTTTTC (PstI) pMAD Cloning
sigV 3V-4V AGATGTACCtGCAGTTTGAATGA (PstI) CAATGACTaGATCtAGGAATCAC (BglII) pMAD Cloning
pMSP V1-2 CGTCTATATAAGTcTgCAGGAAAGG (PstI) GTTGGCGGCATgCTTTTGAAAAG (SphI) pMSP3535 Cloning
Ef0031 2-3r GGTTCTGTATTAGaaTTCGTGGCTA (EcoRI) GTTCCCATACCTGCAGGAACCATAG (PstI) pUCB300 Cloning
dltA RT 1-2 AACCAAGCTTCGATGGTGAA AACGAGCGGCTAATTTCTCA RT-qPCR
LH 54-55 (pgdA) GCGATACCCAGGAGGTCATA ACCATCGCATTCCAGTCAAT RT-qPCR
LH 56-57 (oatA) ACCTTCGTGAAAAAGGGACA GTTGCGCACTTTTAGCGTTT RT-qPCR
SVRT 1-2 (sigV ) CGAAAGAAGATGCCTTGGAT AAGAACCACGCGTCAAAATC RT-qPCR
* Underlined nucleotides stand for the restriction sites (indicated in parenthesis) inserted within the primer sequences and nucleotides in lowercase are different from
those of the target sequence.
doi:10.1371/journal.pone.0009658.t004
Table 3. Bacterial strains and plasmids.
Strains and plasmids Revelant characteristics
Reference or
source
E. faecalis strains
JH2-2 FusR RifR, plasmid-free wild-type strain [59]
DsigV JH2-2 isogenic derivative EF3180 mutant (S26) [26]
DoatA JH2-2 isogenic derivative EF0783 mutant [27]
DdltA JH2-2 isogenic derivative EF2749 mutant this study
DsigV/DoatA JH2-2 isogenic derivative EF3180 and EF0783 double mutant this study
DsigV/DdltA JH2-2 isogenic derivative EF3180 and EF2749 double mutant this study
DoatA/DdltA JH2-2 isogenic derivative EF0783 and EF2749 double mutant this study
DsigV/DoatA/DdltA JH2-2 isogenic derivative EF3180, EF0783, and EF2749 triple mutant this study
SAS JH2-2 isogenic derivative sigV-rsiV double mutant [26]
SAS pMSP3535 EmR, JH2-2 isogenic derivative sigV-rsiV double mutant with pMSP3535 [26]
SAS pMSP3535-sigV EmR, JH2-2 isogenic derivative sigV-rsiV double mutant with pMSP3535-sigV this study
mprF::pUCB300 EmR, JH2-2 isogenic derivative EF0031 mutant this study
E. coli strain
Top10F’ F’ {lacIq Tn10 (TetR)} mcrA D(mrr-hsdRMS-mcrBC) f80lacZDM15 DlacX74
deoR recA1 araD139 D(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG
Invitrogen
Plasmids
pMAD 9.66 kb ori pE194ts, EmR AmpR bgaB [54]
pMAD-DsigV pMAD carrying sigV deletion this study
pMAD-DdltA pMAD carrying dltA deletion this study
pUCB300 3.9 kb, lacZ’ AmpR, EmR [55]
pUCB300-mprF pUCB300 carrying mprF internal fragment this study
pMSP3535 8.35 kb EmR nisR nisK PnisA (nisin inductible promoter) [56]
pMSP3535-sigV pMSP3535 carrying sigV gene this study
Ery, erythromycin; Rif, rifampin; Fus, fusidic acid; Amp, ampicillin; bgaB, b-galactosidase; nis, nisin.
R, resistant;
S, sensitive;
ts, thermosensitive.
doi:10.1371/journal.pone.0009658.t003
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lysozyme. The bacterial growth was evaluated after 48 hours of
incubation at 37uC and photographed.
Nisin sensitivity
In order to assess the effect of nisin on the kinetic growth of E.
faecalis JH2-2 and its derivative mutants, strains were grown on
GM17 to mid-log phase. At this step, 40 ml of fresh medium was
inoculated in order to start the culture from OD600 of 0.05 and
divided into two parts. The first 20 ml culture was carried out
without supplementation (control) and the second received 2 mg/
ml of nisin (Sigma Chemical Co, St. Louis, Mo, USA). The growth
kinetic of the two cultures was then monitored at OD600 nm
during 8 hours.
Triton X-100-induced autolysis assays under non-
growing conditions
Strains were grown to an OD600 of 0.8 in GM17 medium and
treated as previously described [34]. Briefly, cells were harvested
by centrifugation (4000 g, 10 min at 4uC), washed with ice-cold
sterile water, and then resuspended in the same volume of 50 mM
Tris-HCl, pH 7.5, containing 0.05% or 0.1% Triton X-100. The
cell suspensions were then transferred into 100-well sterile micro
plates and incubated at 37uC without shaking. Autolysis was
monitored by measuring OD600 of the cell suspensions every
30 min, with an automated incubator/optical density reader
(Model 680, Bio-Rad Laboratories).
Construction of SAS pMSP3535-sigV strain
In order to overproduce the ECF sigma factor SigV, we cloned
its corresponding gene into pMSP3535 plasmid [56]. Briefly, the
entire gene with its own translation signal was amplified by PCR
using the appropriate primers (Table 4) and then inserted under
the control of the nisin inducible promoter (PnisA) of pMSP3535
plasmid. The subsequent recombinant plasmid (pMSP3535-sigV)
(Table 3) previously obtained in E. coli TOP10F’ was transformed
into electro-competent E. faecalis JH2-2 SAS cells generating the
SAS pMSP3535-sigV strain (Table 3) which overproduces the SigV
sigma factor.
RNA isolation and RT-qPCR experiments
In order to assess comparative transcriptional gene expression,
we used JH2-2 wild-type strain and its sigV derivative mutant
cultured on GM17 medium supplemented with 3 mg/ml
lysozyme. On the other hand, to analyze and verify the effect of
SigV overproduction on oatA, pgdA, dltA and on its own sigV gene
expression, SAS pMSP3535 and SAS pMSP3535-sigV strains
(Table 3) were used under nisin induction. Using RNeasy Midi Kit
(Qiagen, Valencia, Ca, USA), three or two independent samples of
total RNA were isolated for each condition, respectively. Prior to
the extraction, the mid-log phase (OD600 = 0.4) cultures were
treated during 30 minutes with 3 mg/ml lysozyme or 0.5 mg/ml of
nisin.
For reverse transcriptase-quantitative real-time PCR (RT-
qPCR), specific primers were designed using the E. faecalis V583
genome sequence and the Primer3 software (http://frodo.wi.mit.
edu/cgi-bin/primer3/primer3_www.cgi). Primer pairs listed in
Table 4 were designed in order to produce amplicons of equivalent
length (100 bp). Two micrograms (2 mg) of total RNA were reverse
transcribed with random hexamer primers and Omniscript
enzyme (Qiagen). Quantification of 23S rRNA or gyrA (encoding
the gyrase enzyme) levels was used as an internal control.
Amplification (carried out with 5ml of cDNA dilution 1/100),
detection (with automatic calculation of the threshold value), and
real-time analysis were performed twice with cDNA samples using
the iCycler iQ detection system (Bio-Rad Laboratories). The
relative mRNA expression level of each gene in each sample was
calculated using comparative cycle time as described previously
[57].
Animal studies
Animal experiments were performed with the approval of the
Institutional Animal Use and Care Committee at Universita`
Cattolica del S. Cuore, Rome, Italy. Female BALB/c mice, 20 to
25 g, (Harlan Italy S.r.l) were housed in filter-top cages with free
access to food and water at the Catholic University Unit for
Laboratory Animal Medicine. In order to assess the virulence of
the oat, dltA, sigV single-mutant strains and of the oat/dltA/sigV
triple mutant strain with respect to the JH2-2 wild-type strain, two
different mouse models were used.
In the intravenous infection model, experiments were per-
formed according to Gentry-Weeks et al., [35]. Briefly, overnight
cultures of the strains grown in brain-hearth infusion broth (BHI)
supplemented with 40% heat-inactivated horse serum were
centrifuged and the resulting pellets were resuspended in sterile
PBS to achieve final concentrations of 16109 bacteria/ml.
Aliquots of 100 ml from each strain suspension were used to inject
groups of 10 mice into their tail veins. Infections experiments were
repeated three times. The mice were monitored with twice-daily
inspections and they were sacrificed using CO2 inhalation at 7
days after infection. Kidneys and livers were then removed
aseptically, weighed, and homogenized in 5 ml of PBS using a
Stomacher 80 (Pbi International, Milan, Italy) for 120 s at
high speed. Serial homogenate dilutions were plated onto
Enterococcus selective agar (Fluka Analytical, Switzerland) for
CFU determination.
In the urinary tract infection (UTI) model, we followed a
previously described protocol [36]. Briefly, each bacterial strain
was grown in 10 ml of BHI broth supplemented with 40% heat-
inactivated horse serum for 10 h at 37uC under shaking. Cells
were pelleted, resuspended in 10 ml of sterile PBS, and then
adjusted to reach a concentration of 16107 cells/ml. First, groups
of five isoflurane-anesthetized mice per bacterial inoculum (102 to
106 CFU) were infected via intraurethral catheterization (poly-
ethylene catheter, ,4 cm long; outer diameter, 0.61 mm; Becton
Dickinson, Sparks, MD) with 200 ml of each strain suspension.
Additionally, groups of 15 mice were infected with a sole
inoculum of 104 CFU. Mice were sacrificed 48 h after transure-
thral challenge, bladders and kidney pairs were processed as
described above. For each strain, the 50% infective dose (ID50)
was determined as previously described [58]. The bacterial
detection limits were 50 CFU/ml for kidneys and 10 CFU/ml
for bladder homogenates. Differences between the total numbers
of infected kidney pairs or bladders, obtained by combining all
inoculum (102 to 106 CFU) groups were analyzed by Fisher’s
exact test.
For both models, CFU counts were analyzed by unpaired t test.
For all comparisons, a p value of less than 0.05 was considered to
be significant.
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